ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.930
-0.020 (-1.03%)
At close: Mar 20, 2026, 4:00 PM EDT
1.930
0.00 (0.00%)
After-hours: Mar 20, 2026, 6:02 PM EDT
ProKidney Revenue
In the year 2025, ProKidney had annual revenue of $893.00K with 1,075.00% growth. ProKidney had revenue of $225.00K in the quarter ending December 31, 2025, with 196.05% growth.
Revenue (ttm)
$893.00K
Revenue Growth
+1,075.00%
P/S Ratio
305.98
Revenue / Employee
$4,377
Employees
204
Market Cap
273.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 893.00K | 817.00K | 1,075.00% |
| Dec 31, 2024 | 76.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Puma Biotechnology | 228.37M |
| Foghorn Therapeutics | 30.91M |
| Crescent Biopharma | 10.84M |
| Armata Pharmaceuticals | 5.05M |
| Neurogene | 925.00K |
PROK News
- 6 weeks ago - ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably - Seeking Alpha
- 2 months ago - ProKidney Corp. (PROK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates - GlobeNewsWire
- 4 months ago - ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025 - GlobeNewsWire
- 5 months ago - ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 months ago - ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025 - GlobeNewsWire
- 6 months ago - ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy - Seeking Alpha